Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-03

Clinical Trial Update: Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia [NA]

View source ↗

Summary

This clinical trial evaluated the effects of darbepoetin alfa on exercise tolerance and left ventricular structure in patients with symptomatic congestive heart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Congestive Heart Failure, Anemia | NA | Status: COMPLETED